These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9534642)

  • 1. Rescue from neutropenic fever and a bamboo pole.
    Yi CY; Tan IK
    Anaesthesia; 1998 Feb; 53(2):173-6. PubMed ID: 9534642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient.
    Gordon MS; O'Donnell JA; Mohler ER; Cooper MA
    J Heart Lung Transplant; 1993; 12(4):706-7. PubMed ID: 7690254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients.
    Mitchell PL; Morland B; Stevens MC; Dick G; Easlea D; Meyer LC; Pinkerton CR
    J Clin Oncol; 1997 Mar; 15(3):1163-70. PubMed ID: 9060560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
    Tan H; Tomic K; Hurley D; Daniel G; Barron R; Malin J
    Curr Med Res Opin; 2011 Jan; 27(1):79-86. PubMed ID: 21091127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor.
    Nichols CR; Fox EP; Roth BJ; Williams SD; Loehrer PJ; Einhorn LH
    J Clin Oncol; 1994 Jun; 12(6):1245-50. PubMed ID: 7515413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filgrastim and antibiotics treatment reduces neutropenia severity in solid cancer patients.
    Hassan BA; Yusoff ZB; Othman SB
    Asian Pac J Cancer Prev; 2009; 10(4):641-4. PubMed ID: 19827886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.
    Frampton JE; Lee CR; Faulds D
    Drugs; 1994 Nov; 48(5):731-60. PubMed ID: 7530630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing the outcomes in cancer patients receiving chemotherapy through optimal use of colony-stimulating factor.
    Mucenski JW; Shogan JE
    J Manag Care Pharm; 2003; 9(2 Suppl):10-4. PubMed ID: 14613339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy.
    Scott SD; Chrischilles EA; Link BK; Delgado DJ; Fridman M; Stolshek BS
    J Manag Care Pharm; 2003; 9(2 Suppl):15-21. PubMed ID: 14613340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy.
    Weycker D; Malin J; Barron R; Edelsberg J; Kartashov A; Oster G
    Am J Clin Oncol; 2012 Jun; 35(3):267-74. PubMed ID: 21378538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
    Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
    An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
    [No Abstract]   [Full Text] [Related]  

  • 14. Methimazole-induced severe febrile neutropenia responding to recombinant human granulocyte colony stimulating factor.
    Jabr FI
    South Med J; 2008 Jun; 101(6):665. PubMed ID: 18528228
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
    Stahel RA; Jost LM; Cerny T; Pichert G; Honegger H; Tobler A; Jacky E; Fey M; Platzer E
    J Clin Oncol; 1994 Sep; 12(9):1931-8. PubMed ID: 7521907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
    Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
    Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs of treating febrile neutropenia in six U.K. Hospitals.
    Leese B
    Eur J Cancer; 1993; 29A Suppl 7():S15-8. PubMed ID: 7508725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone plus once daily aminoglycoside with filgrastim for treatment of febrile neutropenia: early hospital discharge vs. Standard In-patient care.
    Rapoport BL; Sussmann O; Herrera MV; Schlaeffer F; Otero JC; Pavlovsky S; Iglesias L; Stein G; Charnas R; Heitlinger E; Handschin J
    Chemotherapy; 1999; 45(6):466-76. PubMed ID: 10567777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis.
    Berghmans T; Paesmans M; Lafitte JJ; Mascaux C; Meert AP; Jacquy C; Burniat A; Steels E; Vallot F; Sculier JP
    Support Care Cancer; 2002 Apr; 10(3):181-8. PubMed ID: 11904782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.